Company profile
MicroPort MedBot
MicroPort MedBot develops robot-assisted systems for laparoscopic, orthopaedic, vascular-interventional and other surgical procedures. Its commercial portf...
Facts
- Segment
- SURGICAL
- Country
- China
- Headquarters
- Shanghai, Shanghai
- Founded
- 2015
- Ticker
- 2252
- Website
- https://www.medbotsurgical.com/en/
About MicroPort MedBot
MicroPort MedBot develops surgical robotics across minimally invasive, orthopaedic and vascular-interventional procedures. Its portfolio includes the Toumai laparoscopic platform and SkyWalker orthopaedic system, supported by instruments, planning software and clinical-service infrastructure.
The company is part of the wider MicroPort medical-device group and markets systems across multiple countries. Procedure indications, approvals and availability differ by product and jurisdiction; product-level profiles carry those regulatory qualifications.
Market context
DEPLOYMENT
Summary
Type: Surgical robotics
Core: Toumai / SkyWalker
Function: Robot-assisted surgery
Audience: Surgical teams
Products
- SkyWalker — surgical_robot
- Toumai Surgical Robot — surgical_robot
Research, Articles and recent verified events
- MicroPort MedBot forecasts first half-year profit as Toumai overseas revenue grows — 2026-07-22
- Toumai supports 2,400 km UK-Gibraltar telesurgery — 2026-03-06
- Toumai surpasses 200 global commercial orders — 2026-02-13
- Toumai reaches 100 commercial installations — 2025-12-24
- MicroPort SkyWalker surpasses 500 knee-replacement procedures at Krankenhaus Nettetal — 2025-11-11
- Toumai telesurgery system receives NMPA commercial approval — 2025-05-20